Kapitalo Investimentos’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Kapitalo Investimentos’s Portfolio CYAD Stock Details CYAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-31,326	Closed	-$29.8K	–	742
2023 Q1	$29.8K	Buy	+31,326	New	+$35.5K	0.01%	407

Other funds holding CYAD

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Kapitalo Investimentos's CYAD Position: Q2 2023 in Review

Kapitalo Investimentos sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q2 2023, closing a stake of 31,326 shares — an estimated $29.8K sold.

Kapitalo Investimentos first reported a position in CYAD in Q1 2023 and held it in 1 quarter. The position peaked at $29.8K in Q1 2023. 2 funds tracked by Wall St. Rank hold CYAD as of Q2 2023.

Kapitalo Investimentos reported no remaining Celyad Oncology SA American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Kapitalo Investimentos sold 31,326 Celyad Oncology SA American Depositary Shares shares in Q2 2023, an estimated $29.8K.
Kapitalo Investimentos first reported a position in Celyad Oncology SA American Depositary Shares in Q1 2023 and held it in 1 quarter.
Kapitalo Investimentos's Celyad Oncology SA American Depositary Shares position peaked at $29.8K in Q1 2023.
2 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q2 2023.

Based on Kapitalo Investimentos's 13F filing for Q2 2023, filed 29 Mar 2024.